grant
COBRE Phase III
Organization UNIV OF ARKANSAS FOR MED SCISLocation LITTLE ROCK, UNITED STATESPosted 1 Aug 2025Deadline 31 May 2030
NIHUS FederalResearch GrantFY2025AddressAdverse effectsAdvisory CommitteesApplications GrantsAppointmentAreaArkansasAwardBasic ResearchBasic ScienceBiomedical ResearchCOBRECancer DetectionCancer SurvivorCancer SurvivorshipCancer TreatmentCancersCell Culture TechniquesCenter of Biomedical Research ExcellenceCenters of Research ExcellenceChargeClinicalClinical ResearchClinical StudyCollaborationsCommunicationCore FacilityDisciplineDiscipline of NursingDrugsEarly DiagnosisEducational workshopEffectivenessEnsureEnvironmentEquipmentEvaluationFee-for-Service PlansFees for ServiceFundingFunding AgencyFunding SourceGeneralized GrowthGoalsGrant ProposalsGrowthHuman ResourcesImageImmune responseInstitutionIntervention StrategiesInvestigatorsMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorManpowerMedicalMedicationMethodsModelingNational Institutes of HealthNeeds AssessmentNursingNursing FieldNursing ProfessionOrganPatientsPeer ReviewPersonsPharmaceutical PreparationsPhasePilot ProjectsPrivatizationPublic HealthQOLQualifyingQuality of lifeR-Series Research ProjectsR01 MechanismR01 ProgramRadiationResearchResearch GrantsResearch InfrastructureResearch PersonnelResearch Project GrantsResearch ProjectsResearchersRunningSamplingScienceScientistServicesSourceTask ForcesTestingTissue GrowthToxic effectToxicitiesTrainingTreatment outcomeTreatment-related toxicityUnited States National Institutes of HealthUniversitiesWorkWorkshopadvisory teamanimal imaginganti-cancer therapybasebasescancer survivalcancer therapycancer-directed therapycell culturecell culturescheck point immunotherapycheck point inhibitor therapycheck point inhibitory therapycheck point therapycheckpoint immunotherapycheckpoint inhibitor therapycheckpoint inhibitory therapycheckpoint therapyconferenceconventiondrug/agentearly detectionhost responseimagingimmune check point therapyimmune checkpoint therapyimmune system responseimmunoresponseimprovedinhibitor druginhibitor therapeuticinhibitor therapyinstrumentinterdisciplinary approachinterestirradiationmalignancymeetingmeetingsmembermultidisciplinarymultidisciplinary approachneoplasm/cancernew approachesnovelnovel approachesnovel strategiesnovel strategyontogenypersonnelpilot studypreventpreventingprofessorprogramsproton therapyquality of life and care for cancer survivorsquality of life for cancer survivorsrecruitresponseside effectskillssuccesssummitsymposiasymposiumtenure processtenure tracktherapeutic toxicitytherapy adverse effecttherapy associated toxicitytherapy related toxicitytherapy toxicitytranslational pipelinetranslational spectrumtreatment adverse effecttreatment toxicitytreatment-associated toxicity
Description preview
Overall – Project Summary/Abstract
The overall goal of the Center for Studies of Host Response to Cancer Therapy at the University of Arkansas for
Medical Sciences (UAMS) is to become a self-sustaining multidisciplinary center for research excellence that
contributes to our understanding of mechanisms for side effects of cancer therapy, identifies…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click